Role of apoptosis and transforming growth factor beta 1 in fibroblast selection and activation in systemic sclerosis

Citation
A. Jelaska et Jh. Korn, Role of apoptosis and transforming growth factor beta 1 in fibroblast selection and activation in systemic sclerosis, ARTH RHEUM, 43(10), 2000, pp. 2230-2239
Citations number
53
Categorie Soggetti
Rheumatology,"da verificare
Journal title
ARTHRITIS AND RHEUMATISM
ISSN journal
00043591 → ACNP
Volume
43
Issue
10
Year of publication
2000
Pages
2230 - 2239
Database
ISI
SICI code
0004-3591(200010)43:10<2230:ROAATG>2.0.ZU;2-G
Abstract
Objective. We hypothesized that pathophysiologic events during the developm ent of systemic sclerosis (SSc) may lead to selection and propagation of ce rtain apoptosis-resistant fibroblast subpopulations. The aim of this study was to examine a possible role for apoptosis in fibroblast selection in SSc and the role of transforming growth factor beta 1 (TGF beta 1). Methods. We compared SSc and normal fibroblasts for their susceptibility to anti-Fas-induced apoptosis and analyzed 2 models that might lead to fibrob last resistance to apoptosis in this process: long-term exposure to either anti-Fas or TGF beta 1, Results. SSc-derived fibroblasts were resistant to anti-Fas-induced apoptos is, showing 5.5 +/- 17.2% (mean +/- SD) apoptosis, compared with 32.1 +/- 1 4.0% among normal fibroblasts (P < 0.05), Anti-Fas-selected normal fibrobla sts showed 9.0 +/- 3.7% apoptosis, compared with 21.6 +/- 5.9% for sham-tre ated cells, which is consistent with the elimination of apoptosis-susceptib le subpopulations. Normal fibroblasts subjected to 6 weeks of TGF beta 1 tr eatment showed not only resistance to apoptosis, but also proliferation (11 8.5 +/- 35.4%), after anti-Fas treatment, compared with sham-treated cells (35.1 +/- 11.1% apoptotic cell death). TGF beta 1 treatment also increased the proportion of myofibroblasts (47% versus 28% in controls). Cultured SSc fibroblasts had a greater proportion of myofibroblasts (32-83%) than did n ormal fibroblasts (4-25%). We also examined the relationship between collag en gene expression and the myofibroblast phenotype in normal and SSc skin s ections. Only 2 of 7 normal sections had alpha-smooth muscle actin (alpha-S MA)-positive cells (mean +/- SD score 0.29 +/- 0.49 on a scale of 0-3), but all SSc sections were positive for alpha-SMA, with a mean score of 1.90 +/ - 0.88 for lesional and 1.50 +/- 0.71 for nonlesional sections. Scores for alpha 1(I) procollagen messenger RNA (mRNA) in lesional skin (mean +/- SD 3 .30 +/- 0.82 on a scale of 1-4) were significantly higher than in normal (1 .43 +/- 0.79) or nonlesional (1.40 +/- 0.52) skin, but scores varied, and t here was no correlation between collagen mRNA and alpha-SMA levels. Conclusion. Our results show that resistance to apoptosis is an important p art of the SSc phenotype. TGF beta 1 may play a role by inducing apoptosis- resistant fibroblast populations, and also by inducing myofibroblasts and b y enhancing extracellular matrix synthesis.